Dr. Evan M Graboyes, M.D.
Claim this profileMedical University of South Carolina
Studies Squamous Cell Carcinoma
Studies Neck Cancer
5 reported clinical trials
11 drugs studied
Area of expertise
1Squamous Cell Carcinoma
p16 positive
Stage IV
Stage III
2Neck Cancer
Stage IV
Stage III
p16 positive
Affiliated Hospitals
Clinical Trials Evan M Graboyes, M.D. is currently running
Navigation Intervention
for Head and Neck Cancers
The goal of this clinical trial is to compare the effectiveness of a navigation-based multilevel intervention (ENDURE) with treatment as usual (TAU) to improve the initiation of guideline-adherent postoperative radiation therapy among patients with head and neck cancer. The main questions the trial aims to answer are: 1. Does ENDURE improve initiation of timely PORT relative to treatment as usual? 2. What are the mechanisms through which ENDURE improves timeliness to treatment? 3. What are the barriers and facilitators to the implementation of ENDURE into routine clinical care?
Recruiting1 award N/A7 criteria
Sentinel Lymph Node Biopsy vs Neck Dissection
for Oral Cancer
This phase II/III trial studies how well sentinel lymph node biopsy works and compares sentinel lymph node biopsy surgery to standard neck dissection as part of the treatment for early-stage oral cavity cancer. Sentinel lymph node biopsy surgery is a procedure that removes a smaller number of lymph nodes from your neck because it uses an imaging agent to see which lymph nodes are most likely to have cancer. Standard neck dissection, such as elective neck dissection, removes many of the lymph nodes in your neck. Using sentinel lymph node biopsy surgery may work better in treating patients with early-stage oral cavity cancer compared to standard elective neck dissection.
Recruiting1 award Phase 2 & 3
More about Evan M Graboyes, M.D.
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Evan M Graboyes, M.D. has experience with
- ENDURE
- NDURE
- Attention Control
- BRIGHT
- HN-STAR Intervention
- Computed Tomography (CT)
Breakdown of trials Evan M Graboyes, M.D. has run
Squamous Cell Carcinoma
Neck Cancer
Head and Neck Cancers
Oral Neoplasm
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Evan M Graboyes, M.D. specialize in?
Evan M Graboyes, M.D. focuses on Squamous Cell Carcinoma and Neck Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved p16 positive patients, or patients who are Stage IV.
Is Evan M Graboyes, M.D. currently recruiting for clinical trials?
Yes, Evan M Graboyes, M.D. is currently recruiting for 3 clinical trials in Charleston South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Evan M Graboyes, M.D. has studied deeply?
Yes, Evan M Graboyes, M.D. has studied treatments such as ENDURE, NDURE, Attention Control.
What is the best way to schedule an appointment with Evan M Graboyes, M.D.?
Apply for one of the trials that Evan M Graboyes, M.D. is conducting.
What is the office address of Evan M Graboyes, M.D.?
The office of Evan M Graboyes, M.D. is located at: Medical University of South Carolina, Charleston, South Carolina 29425 United States. This is the address for their practice at the Medical University of South Carolina.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.